| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.5M | +22.6% |
| Cost of Revenue | $13.9M | +31.3% |
| Gross Profit | $647K | -49.2% |
| R&D Expense | $24.1M | +47.9% |
| SG&A Expense | $36.1M | +45.3% |
| Operating Income | -$118.2M | -52.7% |
| Net Income | -$116.7M | -49.0% |
| EPS (Basic) | -$3.88 | -43.2% |
| EPS (Diluted) | -$3.88 | -43.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.8M | -56.0% |
| Short-term Investments | $48.4M | -0.1% |
| Accounts Receivable | $4.2M | +8.4% |
| Inventory | $1.8M | +266.0% |
| Current Assets | $136.0M | -41.6% |
| Total Assets | $202.1M | -18.6% |
| Current Liabilities | $15.6M | +28.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$95.3M | -53.4% |
| Capital Expenditures | $3.3M | +21.5% |
| Investing Cash Flow | -$4.3M | +65.5% |
| Financing Cash Flow | $917K | -99.6% |
| Free Cash Flow | -$98.6M | -52.0% |
| Total Liabilities |
| $69.7M |
| +274.6% |
| Stockholders' Equity | $132.4M | -42.4% |